The report entitled “Global Transcatheter Mitral Valve Replacement (TMVR)Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the
global TMVR market, with detailed analysis of market size and growth,
penetration, market share and economic impact of the industry.
Summary
The mitral valve allows the passage to oxygenated blood from lest atrium
(LA) to the left ventricle (LV) and prevent the backflow of blood back into the
left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart
contraction, blood leaks backward through the mitral valve. This reduces the
amount of blood pumped through the body, which leads to declining heart
function and heart failure, over the time .
The causes of MR disease are congenital heart disorder, rheumatic fever,
trauma, any other heart disease, radiation therapy, etc. The treatments
available for MR disease are surgical repair, drug treatment and replacement.
There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The
DMR and FMR can further be subdivided into many types.
There are different approaches for replacement surgery, depending upon the
type of MR disease. The TMVR market is in very early stage at this moment, with
many companies developing their TMVR devices. The commercial TMVR devices are
expected to be launched in next 2-3 years.
Currently, the global TMVR market is in early stage, but is expected to
increase at high growth rates during the forecasted period (2016-2021). The
global TMVR market is supported by various growth drivers, such as aging population,
high number of cases of congenital heart defects, rheumatic fever, low survival
rate of surgical repair in FMR patients, etc. Yet, the market faces certain
challenges, such as, complexity in design, success of repair surgery in DMR
patients, high number of patients not referred for surgery, etc.
No comments:
Post a Comment